CompletedPhase 1NCT00000992
A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS
Studying Histoplasmosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- LJ Wheat
- Intervention
- Itraconazole(drug)
- Enrollment
- 30 target
- Eligibility
- 13 years · All sexes
- Timeline
- 1992
Study locations (8)
- USC CRS, Los Angeles, California, United States
- Northwestern University CRS, Chicago, Illinois, United States
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis, Indiana, United States
- Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans, Louisiana, United States
- Washington U CRS, St Louis, Missouri, United States
- Cornell University A2201, New York, New York, United States
- Univ. of Cincinnati CRS, Cincinnati, Ohio, United States
- Pitt CRS, Pittsburgh, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00000992 on ClinicalTrials.govOther trials for Histoplasmosis
Additional recruiting or active studies for the same condition.